These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1361819)

  • 1. Growth hormone responses to pituitary and hypothalamic stimuli in CAPD patients treated with recombinant human erythropoietin.
    Díez JJ; Sastre J; Iglesias P; Selgas R; Romero JR; Méndez J; Gómez-Pan A
    Adv Perit Dial; 1992; 8():340-5. PubMed ID: 1361819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone and cortisol secretion before and after erythropoietin therapy in CAPD patients.
    Diez JJ; Iglesias P; Sastre J; Gomez-Pan A; Mendez J; Bajo MA; Selgas R
    Adv Perit Dial; 1994; 10():275-81. PubMed ID: 7999845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of recombinant human erythropoietin treatment on cortisol responses to insulin-induced hypoglycemia in CAPD patients.
    Díez JJ; Iglesias P; Sastre J; Gómez-Pan A; Selgas R; Romero JR; Méndez J
    Adv Perit Dial; 1993; 9():336-41. PubMed ID: 8105958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
    Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
    Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human erythropoietin (rhEPO) treatment potentiates growth hormone (GH) response to growth hormone releasing hormone (GHRH) stimulation in hemodialysis patients.
    Cremagnani L; Cantalamessa L; Orsatti A; Vigna L; Vallino F; Buccianti G
    Clin Nephrol; 1993 May; 39(5):282-6. PubMed ID: 8513607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis.
    Díez JJ; Iglesias P; Sastre J; Aguilera A; Bajo MA; Méndez J; Gómez Pan A; Selgas R
    Metabolism; 1999 Feb; 48(2):210-6. PubMed ID: 10024084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing capd.
    Tokgöz B; Utaş C; Doğukan A; Oymak O; Keleştimur F
    Ren Fail; 2002 May; 24(3):315-23. PubMed ID: 12166698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effect of clonidine and growth hormone (GH)-releasing hormone on GH secretion in adult patients on chronic glucocorticoid therapy.
    Giustina A; Buffoli MG; Bussi AR; Doga M; Girelli A; Pizzocolo G; Pozzi A; Wehrenberg WB
    Horm Metab Res; 1992 May; 24(5):240-3. PubMed ID: 1398465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term erythropoietin therapy on the hypothalamo-pituitary-testicular axis in male CAPD patients.
    Tokgöz B; Utaş C; Dogukan A; Güven M; Taşkapan H; Oymak O; Keleştimur F
    Perit Dial Int; 2001; 21(5):448-54. PubMed ID: 11757827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic clonidine administration on GH secretion in adult human subjects.
    Catania A; Baldini M; Orsatti A; Airaghi L; Gasparini P; Cantalamessa L
    Exp Clin Endocrinol; 1991 Mar; 97(1):76-80. PubMed ID: 1907565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulatory tests of growth hormone secretion in prepubertal major depression: depressed versus normal children.
    Ryan ND; Dahl RE; Birmaher B; Williamson DE; Iyengar S; Nelson B; Puig-Antich J; Perel JM
    J Am Acad Child Adolesc Psychiatry; 1994; 33(6):824-33. PubMed ID: 8083139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in uremic patients.
    Díez JJ; Iglesias PL; Sastre J; Gómez-Pan A; Selgas R; Martínez-Ara J; Miguel JL; Méndez J
    Kidney Int; 1994 Nov; 46(5):1387-91. PubMed ID: 7853798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in basal and stimulated growth hormone secretion in the aging rhesus monkey: a comparison of chair restraint and tether and vest sampling.
    Wheeler MD; Schutzengel RE; Barry S; Styne DM
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1501-7. PubMed ID: 2229308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of corticotropin and growth hormone releasing hormones on their respective secretory axes in chronic hemodialysis patients before and after correction of anemia with recombinant human erythropoietin.
    Ramirez G; Bittle PA; Sanders H; Rabb HA; Bercu BB
    J Clin Endocrinol Metab; 1994 Jan; 78(1):63-9. PubMed ID: 8288716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of growth hormone-releasing hormone and clonidine on growth hormone release in type 1 diabetic patients.
    Giampietro O; Ferdeghini M; Miccoli R; Locatelli V; Cerri M; Yanaihara N; Navalesi R; Müller EE
    Horm Metab Res; 1987 Dec; 19(12):636-41. PubMed ID: 3126122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticoid-induced growth hormone (GH) secretion in GH-deficient and normal children.
    Martul P; Pineda J; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1992 Aug; 75(2):536-9. PubMed ID: 1639956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus aureus nasal carrier status (SANCS) in CAPD patients; is it induced or favored by subcutaneous rHu-erythropoietin?
    Selgas R; Castro MJ; Bajo MA; Fernandez-Reyes MJ; Lopez-Revuelta K; Romero JR; de Alvaro F; Borrego F; Riñon C
    Adv Perit Dial; 1992; 8():253-7. PubMed ID: 1361800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor system components in relation to erythropoietin therapy and bone metabolism in dialyzed patients and kidney transplant recipients.
    Małyszko J; Wołczyński S; Zbroch E; Brzósko S; Małyszko J; Myśliwiec M
    Nephron; 2002 Mar; 90(3):282-9. PubMed ID: 11867949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone response to growth hormone-releasing hormone in normal and uraemic children. Comparison with hypoglycaemia following insulin administration.
    Bessarione D; Perfumo F; Giusti M; Ginevri F; Mazzocchi G; Gusmano R; Giordano G
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):5-11. PubMed ID: 3101340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.